{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:06:16Z","timestamp":1773392776844,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0421"],"award-info":[{"award-number":["W81XWH-21-1-0421"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0420"],"award-info":[{"award-number":["W81XWH-21-1-0420"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implement Sci Commun"],"DOI":"10.1186\/s43058-024-00670-0","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T13:33:15Z","timestamp":1733146395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A qualitative study of perceptions of the care pathway for familial hypercholesterolemia: screening, diagnosis, treatment, and family cascade screening"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0115-8412","authenticated-orcid":false,"given":"Amy R.","family":"Pettit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-5674","authenticated-orcid":false,"given":"Tamar","family":"Klaiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca Connelly","family":"Kersting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1747-2999","authenticated-orcid":false,"given":"Christina","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nkiru","family":"Ogbuefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-5488","authenticated-orcid":false,"given":"Maeve","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystin","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Steckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-2432","authenticated-orcid":false,"given":"Jennifer A.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2498-561X","authenticated-orcid":false,"given":"Adina","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-9267","authenticated-orcid":false,"given":"Mary P.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8098-1990","authenticated-orcid":false,"given":"Eric","family":"Tricou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3174-2552","authenticated-orcid":false,"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9245-9876","authenticated-orcid":false,"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3389-6707","authenticated-orcid":false,"given":"Kevin G.","family":"Volpp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6056-6071","authenticated-orcid":false,"given":"Rinad S.","family":"Beidas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"670_CR1","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","volume":"132","author":"SS Gidding","year":"2015","unstructured":"Gidding SS, Champagne MA, De Ferranti SD, Defesche J, Ito MK, Knowles JW, et al. The agenda for familial hypercholesterolemia: A scientific statement from the American Heart Association. Circulation. 2015;132:2167\u201392. https:\/\/doi.org\/10.1161\/CIR.0000000000000297.","journal-title":"Circulation"},{"key":"670_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013225","volume":"8","author":"MP McGowan","year":"2019","unstructured":"McGowan MP, Hosseini Dehkordi SH, Moriarty PM, Duell PB. Diagnosis and treatment of heterozygous familial hypercholesterolemia. JAHA. 2019;8: e013225.","journal-title":"JAHA"},{"key":"670_CR3","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","volume":"75","author":"SO Beheshti","year":"2020","unstructured":"Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide prevalence of familial hypercholesterolemia. J Amer Coll Cardiol. 2020;75:2553\u201366.","journal-title":"J Amer Coll Cardiol"},{"key":"670_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","volume":"5","author":"AC Goldberg","year":"2011","unstructured":"Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, et al. Familial hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients. J Clin Lipidol. 2011;5:S1-8.","journal-title":"J Clin Lipidol"},{"key":"670_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCRESAHA.114.301430","volume":"114","author":"DM Kusters","year":"2014","unstructured":"Kusters DM, Wiegman A, Kastelein JJP, Hutten BA. Carotid intima-media thickness in children with familial hypercholesterolemia. Circ Res. 2014;114:307\u201310.","journal-title":"Circ Res"},{"key":"670_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40273-023-01347-7","volume":"42","author":"C Marquina","year":"2024","unstructured":"Marquina C, Morton JI, Lloyd M, Abushanab D, Baek Y, Abebe T, et al. Cost-effectiveness of screening strategies for familial hypercholesterolaemia: An updated systematic review. Pharmacoeconomics. 2024;42:373\u201392.","journal-title":"Pharmacoeconomics"},{"key":"670_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","volume":"381","author":"IK Luirink","year":"2019","unstructured":"Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, De Groot E, et al. 20-year follow-up of statins in children with familial hypercholesterolemia. N Engl J Med. 2019;381:1547\u201356.","journal-title":"N Engl J Med"},{"key":"670_CR8","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000625.","DOI":"10.1161\/CIR.0000000000000698"},{"key":"670_CR9","doi-asserted-by":"crossref","unstructured":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics. 2011;128:S213\u201356.","DOI":"10.1542\/peds.2009-2107C"},{"key":"670_CR10","unstructured":"More detailed information on key Tier 1 applications \u2013 Familial hypercholesterolemia [Internet]. Centers for Disease Control and Prevention; 2014. https:\/\/archive.cdc.gov\/www_cdc_gov\/genomics\/implementation\/toolkit\/fh_1.htm. Accessed 24 April 2024."},{"key":"670_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCGENETICS.116.001381","volume":"9","author":"EM deGoma","year":"2016","unstructured":"deGoma EM, Ahmad ZS, O\u2019Brien EC, Kindt I, Shrader P, Newman CB, et al. Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: Data from the CASCADE-FH Registry. Circ Cardiovasc Genet. 2016;9:240\u20139.","journal-title":"Circ Cardiovasc Genet"},{"key":"670_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/heartjnl-2015-308845","volume":"102","author":"M Sharifi","year":"2016","unstructured":"Sharifi M, Rakhit RD, Humphries SE, Nair D. Cardiovascular risk stratification in familial hypercholesterolaemia. Heart. 2016;102:1003\u20138.","journal-title":"Heart"},{"key":"670_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cjca.2012.11.032","volume":"29","author":"TJ Anderson","year":"2013","unstructured":"Anderson TJ, Gr\u00e9goire J, Hegele RA, Couture P, Mancini GBJ, McPherson R, et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013;29:151\u201367.","journal-title":"Can J Cardiol"},{"key":"670_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.hlc.2023.09.012","volume":"32","author":"MN Sarkies","year":"2023","unstructured":"Sarkies MN, Testa L, Best S, Moullin JC, Sullivan D, Bishop W, et al. Barriers to and facilitators of implementing guidelines for detecting familial hypercholesterolaemia in Australia. Heart Lung Circ. 2023;32:1347\u201353.","journal-title":"Heart Lung Circ"},{"key":"670_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11883-023-01090-6","volume":"25","author":"M Sarkies","year":"2023","unstructured":"Sarkies M, Jones LK, Pang J, Sullivan D, Watts GF. How can implementation science improve the care of familial hypercholesterolaemia? Curr Atheroscler Rep. 2023;25:133\u201343.","journal-title":"Curr Atheroscler Rep"},{"key":"670_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12687-018-0383-3","volume":"10","author":"J Zimmerman","year":"2019","unstructured":"Zimmerman J, Duprez D, Veach PM, Zierhut HA. Barriers to the identification of familial hypercholesterolemia among primary care providers. J Community Genet. 2019;10:229\u201336.","journal-title":"J Community Genet"},{"key":"670_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.hlc.2013.08.005","volume":"23","author":"DA Bell","year":"2014","unstructured":"Bell DA, Garton-Smith J, Vickery A, Kirke AB, Pang J, Bates TR, et al. Familial hypercholesterolaemia in primary care: Knowledge and practices among general practitioners in Western Australia. Heart Lung Circ. 2014;23:309\u201313.","journal-title":"Heart Lung Circ"},{"key":"670_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jpeds.2013.10.027","volume":"164","author":"DB Dixon","year":"2014","unstructured":"Dixon DB, Kornblum AP, Steffen LM, Zhou X, Steinberger J. Implementation of lipid screening guidelines in children by primary pediatric providers. J Pediatr. 2014;164:572\u20136.","journal-title":"J Pediatr"},{"key":"670_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/gim.2014.101","volume":"17","author":"NA Mikat-Stevens","year":"2015","unstructured":"Mikat-Stevens NA, Larson IA, Tarini BA. Primary-care providers\u2019 perceived barriers to integration of genetics services: a systematic review of the literature. Genet Med. 2015;17:169\u201376.","journal-title":"Genet Med"},{"key":"670_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2016.07.009","volume":"252","author":"J Schofield","year":"2016","unstructured":"Schofield J, Kwok S, France M, Capps N, Eatough R, Yadav R, et al. Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey Atherosclerosis. 2016;252:161\u20135.","journal-title":"A UK based survey Atherosclerosis"},{"key":"670_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jacl.2014.09.011","volume":"9","author":"J Pang","year":"2015","unstructured":"Pang J, Sullivan DR, Harada-Shiba M, Ding PYA, Selvey S, Ali S, et al. Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study. J Clin Lipidol. 2015;9:42\u20138.","journal-title":"J Clin Lipidol"},{"key":"670_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jacl.2019.01.009","volume":"13","author":"J Pang","year":"2019","unstructured":"Pang J, Chan DC, Hu M, Muir LA, Kwok S, Charng M-J, et al. Comparative aspects of the care of familial hypercholesterolemia in the \u201cTen Countries Study.\u201d J Clin Lipidol. 2019;13:287\u2013300.","journal-title":"J Clin Lipidol"},{"key":"670_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jval.2019.08.011","volume":"23","author":"JA Doshi","year":"2020","unstructured":"Doshi JA, Li P, Puckett JT, Pettit AR, Raman S, Parmacek MS, et al. Trends and factors associated with insurer approval of proprotein convertase subtilisin\/kexin type 9 inhibitor prescriptions. Value Health. 2020;23:209\u201316.","journal-title":"Value Health"},{"key":"670_CR24","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.3390\/jcm10173828","volume":"10","author":"A Smith","year":"2021","unstructured":"Smith A, Johnson D, Banks J, Keith SW, Karalis DG. Trends in PCSK9 inhibitor prescriptions before and after the price reduction in patients with atherosclerotic cardiovascular disease. J Clin Med. 2021;10:3828.","journal-title":"J Clin Med"},{"key":"670_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.atherosclerosis.2018.06.010","volume":"277","author":"MS Hagger","year":"2018","unstructured":"Hagger MS, Hardcastle SJ, Hu M, Kwok S, Lin J, Nawawi HM, et al. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis. 2018;277:493\u2013501.","journal-title":"Atherosclerosis"},{"key":"670_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2021.100180","volume":"6","author":"G Langslet","year":"2021","unstructured":"Langslet G, Johansen AK, Bogsrud MP, Narverud I, Risstad H, Retterst\u00f8l K, et al. Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues. Am J Prev Cardiol. 2021;6: 100180.","journal-title":"Am J Prev Cardiol"},{"key":"670_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.119.002723","volume":"12","author":"C Lee","year":"2019","unstructured":"Lee C, Rivera-Valerio M, Bangash H, Prokop L, Kullo IJ. New case detection by cascade testing in familial hypercholesterolemia: A systematic review of the literature. Circ Genom Precis Med. 2019;12: e002723.","journal-title":"Circ Genom Precis Med"},{"key":"670_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10897-017-0164-x","volume":"27","author":"S Dheensa","year":"2018","unstructured":"Dheensa S, Lucassen A, Fenwick A. Limitations and pitfalls of using family letters to communicate genetic risk: a qualitative study with patients and healthcare professionals. J Genet Couns. 2018;27:689\u2013701.","journal-title":"J Genet Couns"},{"key":"670_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2021.100170","volume":"6","author":"MP McGowan","year":"2021","unstructured":"McGowan MP, Cuchel M, Ahmed CD, Khera A, Weintraub WS, Wilemon KA, et al. A proof-of-concept study of cascade screening for familial hypercholesterolemia in the US, adapted from the Dutch model. Am J Prevent Cardiol. 2021;6: 100170.","journal-title":"Am J Prevent Cardiol"},{"key":"670_CR30","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.gim.2022.08.026","volume":"24","author":"AA Miller","year":"2022","unstructured":"Miller AA, Bangash H, Smith CY, Wood-Wentz CM, Bailey KR, Kullo IJ. A pragmatic clinical trial of cascade testing for familial hypercholesterolemia. Genet Med. 2022;24:2535\u201343.","journal-title":"Genet Med"},{"key":"670_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jacl.2021.01.008","volume":"15","author":"RA Birnbaum","year":"2021","unstructured":"Birnbaum RA, Horton BH, Gidding SS, Brenman LM, Macapinlac BA, Avins AL. Closing the gap: Identification and management of familial hypercholesterolemia in an integrated healthcare delivery system. J Clin Lipidol. 2021;15:347\u201357.","journal-title":"J Clin Lipidol"},{"key":"670_CR32","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/S2589-7500(19)30150-5","volume":"1","author":"KD Myers","year":"2019","unstructured":"Myers KD, Knowles JW, Staszak D, Shapiro MD, Howard W, Yadava M, et al. Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data. Lancet Digit Health. 2019;1:e393-402.","journal-title":"Lancet Digit Health"},{"key":"670_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41746-019-0101-5","volume":"2","author":"JM Banda","year":"2019","unstructured":"Banda JM, Sarraju A, Abbasi F, Parizo J, Pariani M, Ison H, et al. Finding missed cases of familial hypercholesterolemia in health systems using machine learning. NPJ Digit Med. 2019;2:23.","journal-title":"NPJ Digit Med"},{"key":"670_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.120.007641","volume":"14","author":"S Sheth","year":"2021","unstructured":"Sheth S, Lee P, Bajaj A, Cuchel M, Hajj J, Soffer DE, et al. Implementation of a machine-learning algorithm in the electronic health record for targeted screening for familial hypercholesterolemia: A quality improvement study. Circ Cardiovasc Qual. 2021;14: e007641.","journal-title":"Circ Cardiovasc Qual"},{"key":"670_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13012-024-01355-x","volume":"19","author":"C Johnson","year":"2024","unstructured":"Johnson C, Chen J, McGowan MP, Tricou E, Card M, Pettit AR, et al. Family cascade screening for equitable identification of familial hypercholesterolemia: Study protocol for a hybrid effectiveness-implementation type III randomized controlled trial. Implementation Sci. 2024;19:30.","journal-title":"Implementation Sci"},{"key":"670_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/jamainternmed.2016.1691","volume":"176","author":"MS Patel","year":"2016","unstructured":"Patel MS, Day SC, Halpern SD, Hanson CW, Martinez JR, Honeywell S, et al. Generic medication prescription rates after health system\u2013wide redesign of default options within the electronic health record. JAMA Intern Med. 2016;176:847.","journal-title":"JAMA Intern Med"},{"key":"670_CR37","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1377\/hlthaff.2015.1456","volume":"35","author":"JA Doshi","year":"2016","unstructured":"Doshi JA, Lim R, Li P, Young PP, Lawnicki VF, State JJ, et al. A synchronized prescription refill program improved medication adherence. Health Aff (Millwood). 2016;35:1504\u201312.","journal-title":"Health Aff (Millwood)"},{"key":"670_CR38","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1414293","volume":"372","author":"SD Halpern","year":"2015","unstructured":"Halpern SD, French B, Small DS, Saulsgiver K, Harhay MO, Audrain-McGovern J, et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med. 2015;372:2108\u201317.","journal-title":"N Engl J Med"},{"key":"670_CR39","unstructured":"Volpp K, Lowenstein G, Asch D. Behavioral economics and health. (Chapter 481). In: Jameson JL, Hauser SL, Kasper D, Longo DL, Loscalzo J, Fauci A, Hauser S, Kasper D, Longo D, Loscalzo J, editors. Harrison\u2019s Principles of Internal Medicine. 21st edition. NY: McGraw-Hill; 2022."},{"key":"670_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/aje\/kwh236","volume":"160","author":"MA Austin","year":"2004","unstructured":"Austin MA. Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review. Am J Epidemiol. 2004;160:407\u201320.","journal-title":"Am J Epidemiol"},{"key":"670_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/MOL.0b013e3283556c33","volume":"23","author":"A Haase","year":"2012","unstructured":"Haase A, Goldberg AC. Identification of people with heterozygous familial hypercholesterolemia. Curr Opin Lipidol. 2012;23:282\u20139.","journal-title":"Curr Opin Lipidol"},{"key":"670_CR42","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478\u201390.","journal-title":"Eur Heart J"},{"key":"670_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"670_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232076","volume":"15","author":"G Guest","year":"2020","unstructured":"Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS ONE. 2020;15: e0232076.","journal-title":"PLoS ONE"},{"key":"670_CR45","first-page":"31","volume":"10","author":"KM MacQueen","year":"1998","unstructured":"MacQueen KM, McLellan E, Kay K, Milstein B. Codebook development for team-based qualitative analysis. Cult Anthropol Meth. 1998;10:31\u20136.","journal-title":"Cult Anthropol Meth"},{"key":"670_CR46","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.3390\/ijerph19052513","volume":"19","author":"DR Shayani","year":"2022","unstructured":"Shayani DR, Danitz SB, Low SK, Hamilton AB, Iverson KM. Women tell all: A comparative thematic analysis of women\u2019s perspectives on two brief counseling interventions for intimate partner violence. Int J Environ Res Public Health. 2022;19:2513.","journal-title":"Int J Environ Res Public Health"},{"key":"670_CR47","doi-asserted-by":"crossref","unstructured":"Rodriguez R, Imperial JM, Darrel Montefalcon M, Padilla JR, Trillanes A, Abisado M. Comparative thematic analysis of reflections from physical and virtual internship experiences of computing undergraduates students. 2023 11th International Conference on Information and Education Technology (ICIET). Fujisawa, Japan: IEEE; 2023 [cited 2024 Sep 20]. p. 288\u201392. Available from: https:\/\/ieeexplore.ieee.org\/document\/10111418\/.","DOI":"10.1109\/ICIET56899.2023.10111418"},{"key":"670_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13012-021-01111-5","volume":"16","author":"AL Nevedal","year":"2021","unstructured":"Nevedal AL, Reardon CM, Opra Widerquist MA, Jackson GL, Cutrona SL, White BS, et al. Rapid versus traditional qualitative analysis using the Consolidated Framework for Implementation Research (CFIR). Implementation Sci. 2021;16:67.","journal-title":"Implementation Sci"},{"key":"670_CR49","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.1097\/MLR.0000000000001553","volume":"59","author":"AA Lewinski","year":"2021","unstructured":"Lewinski AA, Crowley MJ, Miller C, Bosworth HB, Jackson GL, Steinhauser K, et al. Applied rapid qualitative analysis to develop a contextually appropriate intervention and increase the likelihood of uptake. Med Care. 2021;59:S242\u201351.","journal-title":"Med Care"},{"key":"670_CR50","unstructured":"Service O, Hallsworth M, Halpern D, Algate F, Gallagher R, Nguyen S, et al. EAST: Four simple ways to apply behavioural insights. 2014. https:\/\/www.bi.team\/wp-content\/uploads\/2015\/07\/BIT-Publication-EAST_FA_WEB.pdf. Accessed 24 April 2024."},{"key":"670_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12529-020-09928-y","volume":"28","author":"J Dekker","year":"2021","unstructured":"Dekker J, Amitami M, Berman AH, Brown H, Cleal B, Figueiras MJ, et al. Definition and characteristics of behavioral medicine, and main tasks and goals of the International Society of Behavioral Medicine\u2014an International Delphi Study. Int J Behav Med. 2021;28:268\u201376.","journal-title":"Int J Behav Med"},{"key":"670_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ahj.2020.10.058","volume":"232","author":"JH Berger","year":"2021","unstructured":"Berger JH, Chen F, Faerber JA, O\u2019Byrne ML, Brothers JA. Adherence with lipid screening guidelines in standard- and high-risk children and adolescents. Am Heart J. 2021;232:39\u201346.","journal-title":"Am Heart J"},{"key":"670_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-2004-822992","volume":"4","author":"D Wonderling","year":"2004","unstructured":"Wonderling D, Umans-Eckenhausen M, Marks D, Defesche J, Kastelein J, Thorogood M. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in the Netherlands. Semin Vasc Med. 2004;4:97\u2013104.","journal-title":"Semin Vasc Med"},{"key":"670_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","volume":"357","author":"MA Umans-Eckenhausen","year":"2001","unstructured":"Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder RL, Kastelein JJ. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357:165\u20138.","journal-title":"Lancet"},{"key":"670_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implementation Sci. 2022;17:75.","journal-title":"Implementation Sci"},{"key":"670_CR56","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3390\/curroncol29040195","volume":"29","author":"SD Hohl","year":"2022","unstructured":"Hohl SD, Bird JE, Nguyen CVT, D\u2019Angelo H, Minion M, Pauk D, et al. Operationalizing leadership and clinician buy-in to implement evidence-based tobacco treatment programs in routine oncology care: A mixed-method study of the U.S. Cancer Center Cessation Initiative. Current Oncology. 2022;29:2406\u201321.","journal-title":"Current Oncology."},{"key":"670_CR57","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1108\/JHOM-08-2020-0335","volume":"35","author":"A De Br\u00fan","year":"2021","unstructured":"De Br\u00fan A, McAuliffe E. The RELATE model: Strategies to effectively engage healthcare organisations to create amenable contexts for implementation. J Health Organ Manag. 2021;35:338\u201348.","journal-title":"J Health Organ Manag"},{"key":"670_CR58","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.aau9241","volume":"361","author":"RH Thaler","year":"2018","unstructured":"Thaler RH. Nudge, not sludge. Science. 2018;361:431.","journal-title":"Science"},{"key":"670_CR59","first-page":"254","volume":"43","author":"DM Tarn","year":"2011","unstructured":"Tarn DM, Flocke SA. New prescriptions: how well do patients remember important information? Fam Med. 2011;43:254\u20139.","journal-title":"Fam Med"},{"key":"670_CR60","first-page":"233339282095090","volume":"7","author":"P Ramar","year":"2020","unstructured":"Ramar P, Roellinger DL, Merrick RF, Ebbert JO, Philpot LM. Helpfulness of clinical visit summary content from multi-specialty care: A mixed-methods assessment. Health Serv Res Manag Epidemiol. 2020;7:233339282095090.","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"670_CR61","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s11606-020-06540-4","volume":"36","author":"T Ho","year":"2021","unstructured":"Ho T, Campos BS, Tarn DM. Post-visit patient understanding about newly prescribed medications. J Gen Intern Med. 2021;36:3307\u201310.","journal-title":"J Gen Intern Med"},{"key":"670_CR62","doi-asserted-by":"publisher","unstructured":"Drisko JW. Transferability and generalization in qualitative research. Res Soc Work Prac. 2024;10497315241256560.\u00a0https:\/\/doi.org\/10.1177\/10497315241256560.","DOI":"10.1177\/10497315241256560"}],"container-title":["Implementation Science Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-024-00670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43058-024-00670-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-024-00670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T14:03:18Z","timestamp":1733148198000},"score":1,"resource":{"primary":{"URL":"https:\/\/implementationsciencecomms.biomedcentral.com\/articles\/10.1186\/s43058-024-00670-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1186\/s43058-024-00670-0","relation":{},"ISSN":["2662-2211"],"issn-type":[{"value":"2662-2211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Pennsylvania Institutional Review Board (Protocol #849516). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"At the time of the study, MPM was Chief Medical Officer at the nonprofit Family Heart Foundation. ET is a genetic counselor and care navigator at the Family Heart Foundation. DJR is the Chief Scientific Advisor and immediate past Chair of the Board at the Family Heart Foundation and is on the Scientific Advisory Board of Alnylam Pharmaceuticals, Novartis, and Verve Therapeutics. He is a founder of VascularStrategies LLC and a consultant for Regeneron Pharmaceuticals, Inc. KGV is a part-owner of VALHealth, a behavioral economics consulting firm, and receives research funding from Independence Blue Cross and research funding and consulting support from the American Heart Association, none of which are related to the work described in this manuscript. He is also a Scientific Advisory Board member of Thrive Global and receives equity stock options for his role (also unrelated to this manuscript). RSB is the principal at Implementation Science & Practice, LLC. She receives royalties from Oxford University Press and consulting fees from United Behavioral Health and OptumLabs. She is currently an appointed member of the National Advisory Mental Health Council and the NASEM study, \u201cBlueprint for a National Prevention Infrastructure for Behavioral Health Disorders,\u201d and serves on the advisory boards for AIM Youth Mental Health Foundation and the Klingenstein Third Generation Foundation, outside of the submitted work. The remaining authors (ARP, TK, RCK, CJ, NO, MM, KS, JS, LN, JAO, AL, and JC) declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}